Serum Institute of India has got Drug Controller General of India's green signal to manufacture Russia's Sputnik V Covid-19 vaccine in the country for examination, test and analysis with certain conditions, official sources said today.
Sputnik V vaccine, the third vaccine to be added to India's inoculation campaign after Covishield and Covaxin, is currently being manufactured in India by Dr Reddy''s Laboratories.
"The DCGI has granted permission to the Serum Institute to manufacture the Sputnik Covid-19 vaccine in India for examination, test and analysis at its licensed Hadapsar facility with certain conditions," the sources said.
"The Serum Institute of India put up an application to the Drugs Controller General of India on Wednesday seeking permission for a test licence to manufacture the Covid-19 vaccine, Sputnik V, in India," they said.
Pune-based SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, to develop Sputnik V.